Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Adam Haluszczuk
Introduction
Adam Haluszczuk is a notable inventor based in Gdansk, Poland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on chemical compounds. His expertise and dedication to research have led to the development of a unique pharmaceutical intermediate.
Latest Patents
Haluszczuk holds a patent for a pharmaceutical intermediate, specifically 4-(4-fluorobenzylamino)-1-methylpiperidine trihydrate. This invention involves a process for preparing this compound by treating 4-(4-fluorobenzylamino)-1-methylpiperidine with water. Additionally, the patent outlines a method for synthesizing pimavanserin by reacting the trihydrate with 1-isobutoxy-4-(isocyanatomethyl)benzene. The invention also includes processes for creating pimavanserin acid addition salts and highlights the use of the trihydrate in the preparation of these compounds.
Career Highlights
Haluszczuk is currently employed at Zakłady Farmaceutyczne Polpharma S.A., a leading pharmaceutical company in Poland. His role at Polpharma allows him to apply his innovative ideas and contribute to the development of new pharmaceutical products. His work has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Haluszczuk has collaborated with talented professionals, including Dorota Pogoda and Kamil Kosik. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the research process.
Conclusion
Adam Haluszczuk's contributions to the pharmaceutical industry exemplify the impact of innovation in medicine. His patent for a pharmaceutical intermediate showcases his commitment to advancing healthcare solutions. His work continues to inspire future developments in the field.